Evidence map›Paper›PMID 29547621›Full record

ArticlePloS one2018

Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.

Hirofumi Chiba, Yoichi Kakuta, Yoshitaka Kinouchi, Yosuke Kawai, Kazuhiro Watanabe, Munenori Nagao, Takeo Naito, Motoyuki Onodera, Rintaro Moroi, Masatake Kuroha and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. International journal of molecular sciences · 2020
    Article
  7. Article
  8. Article
  9. Methylenetetrahydrofolate Dehydrogenase 1 Silencing Expedites the Apoptosis of Non-Small Cell Lung Cancer Cells via Modulating DNA Methylation.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Hirofumi ChibaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoichi KakutaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoshitaka KinouchiInstitute for Excellence in Higher Education, Tohoku University, Sendai, Japan.
Yosuke KawaiTohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Kazuhiro WatanabeDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Munenori NagaoDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Takeo NaitoDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Motoyuki OnoderaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Rintaro MoroiDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masatake KurohaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yoshitake KanazawaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tomoya KimuraDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hisashi ShigaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Katsuya EndoDivision of Gastroenterology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Kenichi NegoroDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Masao NagasakiInstitute for Excellence in Higher Education, Tohoku University, Sendai, Japan.
Michiaki UnnoDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tooru ShimosegawaDivision of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tohoku University · JPTohoku Medical and Pharmaceutical University · JPTohoku Medical Megabank Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInflammatory bowel disease (IBD) has an unknown etiology; however, accumulating evidence suggests that IBD is a multifactorial disease influenced by a combination of genetic and environmental factors. The influence of genetic variants on DNA methylation in cis and cis effects on expression have been demonstrated. We hypothesized that IBD susceptibility single-nucleotide polymorphisms (SNPs) regulate susceptibility gene expressions in cis by regulating DNA methylation around SNPs. For this, we determined cis-regulated allele-specific DNA methylation (ASM) around IBD susceptibility genes in CD4+ effector/memory T cells (Tem) in lamina propria mononuclear cells (LPMCs) in patients with IBD and examined the association between the ASM SNP genotype and neighboring susceptibility gene expressions.

methodsCD4+ effector/memory T cells (Tem) were isolated from LPMCs in 15 Japanese IBD patients (ten Crohn's disease [CD] and five ulcerative colitis [UC] patients). ASM analysis was performed by methylation-sensitive SNP array analysis. We defined ASM as a changing average relative allele score ([Formula: see text]) >0.1 after digestion by methylation-sensitive restriction enzymes. Among SNPs showing [Formula: see text] >0.1, we extracted the probes located on tag-SNPs of 200 IBD susceptibility loci and around IBD susceptibility genes as candidate ASM SNPs. To validate ASM, bisulfite-pyrosequencing was performed. Transcriptome analysis was examined in 11 IBD patients (seven CD and four UC patients). The relation between rs36221701 genotype and neighboring gene expressions were analyzed.

resultsWe extracted six candidate ASM SNPs around IBD susceptibility genes. The top of [Formula: see text] (0.23) was rs1130368 located on HLA-DQB1. ASM around rs36221701 ([Formula: see text] = 0.14) located near SMAD3 was validated using bisulfite pyrosequencing. The SMAD3 expression was significantly associated with the rs36221701 genotype (p = 0.016).

conclusionsWe confirmed the existence of cis-regulated ASM around IBD susceptibility genes and the association between ASM SNP (rs36221701) genotype and SMAD3 expression, a susceptibility gene for IBD. These results give us supporting evidence that DNA methylation mediates genetic effects on disease susceptibility.

Indexed as

AdolescentAdultAgedAllelesAsian PeopleCD4-Positive T-LymphocytesDNA MethylationFemaleGenetic Predisposition to DiseaseGenotypeHumansImmunologic MemoryInflammatory Bowel DiseasesMaleMiddle AgedPolymorphism, Single Nucleotide

Identifiers

PMID29547621
PMCPMC5856270
OpenAlexW4237257437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.